Publikationen, an denen er mitarbeitet Antoni Bayes Genis (20)

2024

  1. Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA)

    European Journal of Heart Failure

2023

  1. Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study

    European Journal of Heart Failure, Vol. 25, Núm. 8, pp. 1352-1360

  2. Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat

    Patient Preference and Adherence, Vol. 17, pp. 839-849

  3. Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension

    European Journal of Heart Failure, Vol. 25, Núm. 7, pp. 936-955

2022

  1. Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials

    American journal of therapeutics, Vol. 29, Núm. 5, pp. e572-e575

  2. Vericiguat in heart failure: from scientific evidence to clinical practice

    Revista Clinica Espanola

2021

  1. Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI)

    Basic Research in Cardiology, Vol. 116, Núm. 1

  2. Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival

    Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21

2020

  1. Intracoronary lithotripsy in a high-risk real-world population. First experience in severely calcified, complex coronary lesions

    REC: Interventional Cardiology, Vol. 2, Núm. 2, pp. 76-81

  2. Litotricia intracoronaria en pacientes de la vida real: Primera experiencia en lesiones complejas y gravemente calcificadas

    REC: Interventional Cardiology, Vol. 2, Núm. 2, pp. 76-81

2018

  1. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial

    European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264

2016

  1. Documento de consenso y recomendaciones sobre el uso de los péptidos natriuréticos en la práctica clínica

    Revista Clinica Espanola, Vol. 216, Núm. 6, pp. 313-322

  2. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: Results from the MAGGIC individual patient data meta-analysis

    QJM, Vol. 109, Núm. 6, pp. 377-382

  3. Péptidos natriuréticos: consenso y uso necesarios

    Revista Espanola de Cardiologia, Vol. 69, Núm. 9, pp. 817-819

2013

  1. Spironolactone in mild chronic heart failure: Insights from a propensity-matched analysis of the MUSIC study cohort

    International Journal of Cardiology, Vol. 168, Núm. 4, pp. 4525-4527

2009

  1. Risk Stratification of Mortality in Patients With Heart Failure and Left Ventricular Ejection Fraction >35%

    American Journal of Cardiology, Vol. 103, Núm. 7, pp. 1003-1010

  2. The MUSIC Risk score: A simple method for predicting mortality in ambulatory patients with chronic heart failure

    European Heart Journal, Vol. 30, Núm. 9, pp. 1088-1096

2008

  1. Association of Blood Pressure and Its Evolving Changes With the Survival of Patients With Heart Failure

    Journal of Cardiac Failure, Vol. 14, Núm. 7, pp. 561-568

  2. Prognostic value of QT/RR slope in predicting mortality in patients with congestive heart failure

    Journal of Cardiovascular Electrophysiology, Vol. 19, Núm. 10, pp. 1066-1072

2007

  1. Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure

    European Journal of Heart Failure, Vol. 9, Núm. 8, pp. 802-807